This study investigates the efficiency of the new CDF appraisal process for indications without prio...
Read moreThis study investigates NICE's evaluation of existing CDF treatments and its potential impact on fun...
Read moreThis process aims to be completely transparent , to enable faster patient access to oncology treatme...
Read moreTopics include our perspectives on an EU commission report on how international reference pricing ca...
Read moreFrom July 2016 NICE will gain decision power by saying yes, no or maybe to cancer drugs entering the...
Read moreThe aim of this study was to assess the launch price of mCRPC treatments across the EU5 (France, Ger...
Read moreThe proposal states that the CDF should become a "managed access" fund for new cancer dugs, with cle...
Read moreIn this issue is an overview of the future changes to the UK Cancer Drug Fund as well as approaches ...
Read moreNHS England have recently proposed that NICE should take a more direct role in determining which pro...
Read morePharmaceutical companies are able to charge significantly higher prices as these products are addres...
Read more